Richard Greil
Top Publications Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study (2019) – 3,363 citations Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer (2019) – 1,352 citations Continuation of bevacizumab after first progression in metastatic ... <a title="Richard Greil" class="read-more" href="https://journalsworld.com/researchers/richard-greil/" aria-label="Read more about Richard Greil">Read more</a>
Read biography ↓Biography, research & contributions
Top Publications
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study (2019) - 3,363 citations
- Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer (2019) - 1,352 citations
- Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial (2012) - 1,177 citations
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer (2009) - 1,026 citations
- Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma (2010) - 933 citations
At a glance
- Full name
- Richard Greil
- ORCID
- 0000-0002-4462-3694
- OpenAlex ID
- https://openalex.org/A5039994927
Research interests
- Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Breast Cancer Treatment Studies, Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies
Research topics
Education
Not yet documented in this profile.
Selected research & further reading
A curated reading list, not a ranking by citation count. References use DOI metadata, matching public scholarly records or authoritative lecture sources.
See the source-linked reading and original works in the research guide above.
Citation & publication trends
Annual counts are not yet available from a verified author record. Explore the research guide above for the work itself; publication and citation totals depend on database coverage.
Source: OpenAlex · Retrieved 2026-10-08. Metrics are database-specific and are not a scientific ranking.
Most-cited linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- 3,363OpenAlex citations
- Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer ↗2019 · New England Journal of Medicine1,352OpenAlex citations
- 1,177OpenAlex citations
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer ↗2009 · New England Journal of Medicine1,026OpenAlex citations
- Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma ↗2010 · New England Journal of Medicine933OpenAlex citations
Recent linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer ↗2019 · New England Journal of Medicine
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer ↗2009 · New England Journal of Medicine
- Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma ↗2010 · New England Journal of Medicine
Journals published in
No verified record links added yet.
Related publishers
No verified record links added yet.
Institutions
Current verified institution
No verified record links added yet.
Previous institutions
No verified record links added yet.
Awards & honors
Not yet documented in this profile.
Career timeline
Not yet documented in this profile.
Co-authors
No verified record links added yet.
Education & career institution links
No verified record links added yet.
Claim & manage this profile
Are you this researcher? Sign in, provide identity evidence, and request administrator approval. Editing becomes available only after approval.
Sign in to claim this profileSources & data information
Editorial review: 2026-10-08 · Last data update: 2026-10-08 00:00:38
Unknown values are left blank. Linked publications may be a subset of total works. Identity verification, data retrieval and profile ownership are separate checks.